methyl 5-(4-methoxyphenyl)pent-4-ynoate | 1061175-68-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: methyl 5-(4-methoxyphenyl)pent-4-ynoate
• 英文别名: Methyl 5-(4-methoxyphenyl)pent-4-ynoate
• CAS: 1061175-68-5
• 化学式: C₁₃H₁₄O₃
• 分子量: 218.252
• InChiKey: RMVUCNNXWDUCTN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  16
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.31
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  methyl 5-(4-methoxyphenyl)pent-4-ynoate 在 potassium hydroxide 作用下， 以 1,4-二氧六环 、 水 为溶剂， 生成 5-(4-methoxyphenyl)pent-4-ynoic acid
  参考文献：
  名称：

  Gold-Catalyzed Cycloisomerization of 1,6-Diyne Carbonates and Esters to 2,4a-Dihydro-1H-fluorenes

  摘要：

  A synthetic method to prepare 2,4a-dihydro-1H-fluorenes efficiently from gold(I)-catalyzed 1,2-acyloxy migration/cyclopropenation/Nazarov cyclization of 1,6-diyne carbonates and esters is described. The suggested reaction pathway provides rare examples of [2,3]-sigmatropic rearrangement in this class of compounds as well as the involvement of an in situ formed cyclopropene intermediate in gold catalysis. Experimental and ONIOM(QM:QM') [our own n-layered integrated molecular orbital and molecular mechanics(quantum mechanics quantum mechanics')] computational studies based on the proposed Au carbenoid species provide insight into this unique selectivity.

  DOI：

  10.1021/ja4032727
• 作为产物：
  描述：

  (4-甲氧基苯乙炔基)三甲基硅烷 、 丙烯酸甲酯（MA） 在 indium(III) chloride 、 三乙胺 作用下， 以 氯苯 为溶剂， 反应 16.0h， 以93%的产率得到methyl 5-(4-methoxyphenyl)pent-4-ynoate
  参考文献：
  名称：

  氯化铟（III）催化炔烷基硅烷与丙烯酸酯的共轭加成反应

  摘要：

  已经开发了在催化量的氯化铟（III）存在下通过将炔基硅烷共轭加成到丙烯酸酯上来合成δ，γ-炔基酯的新颖有效的方法。该方法提供了快速有效地获得取代的δ，γ-炔基酯的方法。

  DOI：

  10.1021/jo202628c

文献信息

• Palladium-catalyzed 1,4-addition of terminal alkynes to unsaturated carbonyl compounds promoted by electron-rich ligands
  作者：Lei Zhou、Liang Chen、Rachid Skouta、Huan-feng Jiang、Chao-Jun Li

  DOI：10.1039/b805946m

  日期：——

  The efficient palladium-catalyzed conjugate addition of terminal alkynes to α,β-unsaturated carbonyl compounds has been developed using electron-rich ligands, producing the corresponding γ,δ-alkynyl ketone and γ,δ-alkynyl esters in good yields.

  利用富电子配体，已经开发出了高效的钯催化端炔对α,β-不饱和羰基化合物的共轭加成反应，产率良好地得到了相应的γ,δ-炔基酮和γ,δ-炔基酯。
• Light‐Driven Enantioselective Synthesis of Pyrroline Derivatives by a Radical/Polar Cascade Reaction
  作者：Ricardo I. Rodríguez、Leonardo Mollari、José Alemán

  DOI：10.1002/anie.202013020

  日期：2021.2.23

  functionalization of acyl heterocycles through a hydrogen‐atom transfer (HAT) process and the use of tailor‐made ketimines as reliable electrophilic partners. This transformation is translated into an enantiomerically controlled radical/polar cascade reaction in which water is produced as the sole by‐product and stereoselectivity is dictated by coordination to a chiral‐at‐rhodium catalyst.

  在此，介绍了一种光驱动、原子经济的过程，该过程提供了获得对映体富集的取代手性 1-吡咯啉衍生物的途径。该策略涉及通过氢原子转移（HAT）过程对酰基杂环进行远端官能化，并使用定制的酮亚胺作为可靠的亲电伙伴。这种转变转化为对映体控制的自由基/极性级联反应，其中产生的唯一副产物是水，立体选择性取决于与铑手性催化剂的配位。
• Synthesis and biological evaluation of novel 4-hydroxytamoxifen analogs as estrogen-related receptor gamma inverse agonists
  作者：Jina Kim、Jungwook Chin、Chun Young Im、Eun Kyung Yoo、Seoyeon Woo、Hee Jong Hwang、Joong-heui Cho、Kyung-ah Seo、Jaeyoung Song、Hayoung Hwang、Kyung-Hee Kim、Nam Doo Kim、Suk Kyoon Yoon、Jae-Han Jeon、Seung-Yun Yoon、Yong Hyun Jeon、Hueng-Sik Choi、In-Kyu Lee、Seong Heon Kim、Sung Jin Cho

  DOI：10.1016/j.ejmech.2016.04.076

  日期：2016.9

  Estrogen-related receptor gamma (ERRγ) has recently been recognized as an attractive target for treating inflammation, cancer, and metabolic disorders. Herein, we discovered and demonstrated the in vitro pharmacology as well as the absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties of chemical entities that could act as highly selective inverse agonists for ERRγ. The results were comparable to those for GSK5182 (4), a leading ERRγ inverse agonist ligand. Briefly, the half-maximal inhibitory concentration (IC50) range of the synthesized compounds for ERRγ was 0.1-10 μM. Impressively, compound 24e exhibited potency comparable to 4 but was more selective for ERRγ over three other subtypes: ERRα, ERRβ, and estrogen receptor α. Furthermore, compound 24e exhibited a superior in vitro ADMET profile compared to the other compounds. Thus, the newly synthesized class of ERRγ inverse agonists could be lead candidates for developing clinical therapies for ERRγ-related disorders.